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Abstract
Background: Cultures for urinary tract infections (UTI) con-
stitute a large workload in the clinical microbiology labora-
tory, although up to 80% are usually negative. Several
automated methods are available to screen urines for UTI,
one being the flow cytometry-based Sysmex UF-100.
Methods: The performance of the UF-100 was evaluated
over a 16-month period using urine culture as the reference
method.
Results: During this period, a total of 5356 urine samples
were studied (469 children; 3229 women and 1658 men), of
which 706 were culture positive (593 grew Gram negative
bacilli). Receiver operating characteristics (ROC) curve anal-
ysis showed an area under the curve (AUC) of 0.83 for leu-
kocytes and 0.85 for bacterial count. Applying cut-off values
reported in the literature gave sensitivities ranging from 75%
to 90%, resulting in 73–174 false negatives (FN). Using a
logical combination (leukocytes G15=106/L OR bacteria
G500=106/L) gave a sensitivity of 98%. However, the spec-
ificity dropped to 25%, resulting in 15 FN.
Conclusions: Screening urine samples for UTI detects a
large number of culture positive samples. However, the rath-
er large number of FN observed precludes the use of the UF-
100 as a routine screening method to exclude urine samples
from culture.
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Introduction
Urine culture is of the most frequent culture analysis per-
formed in the clinical microbiology laboratory. However,
70%–80% of cultures are negative (1, 2). In the author’s
institution, ;26,000 urine cultures were performed during
2008, 19% of which were culture positive. Negative urine
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cultures lead to considerable workload and consumption of
resources, an important aspect in times of ever increasing
cost restrains. This has led to the development and imple-
mentation of screening methods to identify urinary tract
infections (UTI). One of the first automated methods for
urine sediment testing was based on image analysis (3, 4).
However, these systems still require an operator to visually
inspect images of cells and casts (5). Around the same time,
improved urinary test strips and instruments for reading
them, were being developed (6). Screening for UTI was
based on the detection of nitrite and leukocyte esterase (7,
8). However, false negative (FN) and/or false positive results
were too frequent, precluding use of this approach as a
screening method for UTI (9, 10).
Recent approaches based on flow cytometry allow detec-
tion and counting of large numbers of particles in a short
period of time, including bacteria and yeast (6). One such
instrument for this purpose is the Sysmex UF-100. Several
studies reported acceptable performance for this instrument
(6, 11–13). However, reported results for sensitivity and
specificity varied significantly, with some showing a rather
high number of FN results (1, 2). For example, some studies
used higher cut offs, e.g., 300=107 bacteria/L (11, 12), in
an attempt to increase the specificity to )60%, while main-
taining sensitivity above 90%. However, it appears that most
or all of the samples were not from hospital acquired UTIs
(11, 12).
The goal of this study was to evaluate the Sysmex UF-
100 system to screen urine for UTI under routine conditions
in an unselected population at a major tertiary referral centre.
Materials and methods
The study was performed and approved within the ethical frame-
work of the hospital. The study includes data from inpatients and
outpatients that had a urine culture and a flow cytometric urine
screen (Sysmex UF-100, TOA Medical Electronics/Europe GmbH,
Hamburg, Germany) performed between January 2008 and June
2009. Urine was collected into a Urine-Monovette (Sarstedt,
Nürmbrecht, Germany) containing boric acid for urine culture, while
Urine-Monovette tubes without boric acid were used for the flow
cytometric and dipstick analysis. Only those samples were consid-
ered where both Monovette tubes were logged into the Laboratory
Information System of the Clinical Chemistry and Microbiology
Department -1 h apart.
Dipstick urinalysis was performed using the automated Urisys
2400 (Roche Diagnostic Systems, Lisbon, Portugal).
Manual microscopy sediment analysis was performed according
to CLSI GP 16-A guideline (14). Each sample was centrifuged at
400 g for 10 min, the supernatant was decanted and the sediment
mixed in the residual volume. At a 400= magnification, 20 random
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Table 1 Bacterial isolates from positive urine cultures (ns706).
Bacteria Children Adult, Adult,
(-16 years) male female
Gram negative bacilli 49 140 404
Escherichia coli 26 78 287
Proteus mirabilis 7 11 40
Pseudomonas spp. 2 17 18
Klebsiella spp. 8 19 44
Other 6 15 15
Gram positive cocci 10 47 56
Group B Streptococcus 0 3 23
Enterococcus spp. 7 25 22
Staphylococcus spp. 3 19 11
Total 59 187 460
OthersMorganella morganii; Serratia spp.; Citrobacter spp.;
Enterobacter spp.; Providencia spp.; Stenotrophomonas
maltophilia.
Figure 1 ROC curve for leukocyte and bacterial counts (ns5356).
Receiver operating characteristics (ROC) curve for bacteria and leu-
kocyte counts on the Sysmex UF-100 flow cytometer, using urine
culture as the reference method. The area under the curve (AUC) is
0.83 for leukocytes and 0.85 for bacterial counts (0.5–0.7: low accu-
racy, 0.7–0.9: moderate accuracy and )0.9 high accuracy). ROC
curve generated with SPSS Statistics V17.0.
microscopic fields were examined and the mean number of cells
per field were calculated.
Urine cultures were performed by inoculating well mixed, uncen-
trifuged urine on horse blood agar and MacConkey agar plates
(bioMérieux, Lisbon, Portugal). Growth was assessed after over-
night incubation at 368C. Urine cultures were considered negative
if no growth occurred or with growth -106 CFU/L. If more than
two types of bacteria grew, samples were considered contaminated.
If growth of a pure culture occurred, samples were considered pos-
itive in the presence of leukocyturia (at least 5 leukocytes/micro-
scopic field). However, in certain patient groups, such as children,
immunocompromised, transplant recipients or pregnant women,
growth of a pure culture was considered positive, even in the case
of -5 leukocytes/microscopic field. Microorganisms were identi-
fied by conventional biochemical tests using the WalkAway96 sys-
tem (Dade Behring, Marburg GmbH, Germany) and/or the VITEK
system (bioMérieux, Lisbon, Portugal).
For flow cytomeric urine screening, the Sysmex UF-100 was
used. This system analyzes formed elements in urine, including
cells, based on flow cytometry and impedance detection as
described previously (15, 16). In cases where patients had multiple
samples processed, only the first sample was considered. Samples
that were considered to represent bacterial contamination were
excluded. The culture results were used as the reference method to
evaluate the performance of the Sysmex UF-100 as a screening
method for UTI.
Data were analyzed using SPSS Statistics V17.0 (SPSS Inc, Chi-
cago, IL, USA).
Results
A total of 5356 (4650 culture negative and 706 culture pos-
itive) urine samples fullfield the inclusion criteria. Of these,
469 were from children -16 years (mean: 6 years, range:
2 days–15 years), 3229 from female patients (mean:
50 years, range: 16–100 years) and 1658 from male patients
(mean: 62 years, range: 16–97 years). Bacteria that were
isolated are shown in Table 1.
Receiver operating characteristics (ROC) curve analysis
(Figure 1) showed an area under the curve (AUC) of 0.83
and 0.85 for leukocytes and bacterial counts, respectively.
Results obtained at different cut-off thresholds are shown in
Table 2.
The best cut-off was the combination leukocytesG
15=106/L OR Bacteria G500=106/L, which produced a
sensitivity of 98%, but a specificity of only 25%, resulting
in 15 FN. Of these FN, two were from Obstetrics and three
from the Nephrology Department. Underlying conditions
most frequently associated with FN were renal transplanta-
tion (ns2), pregnancy (ns2), urinary tract structural pro-
blems (ns4), immunosuppression (ns2) and antibiotherapy
(ns2).
Discussion
Urine cultures constitute a major part of the clinical micro-
biology workload. Considering that 70%–80% of urine cul-
tures are usually negative (1, 2), a screening test that reliably
identifies samples from patients with a UTI would have a
major impact, and large cost savings could be achieved.
The appearance of flow cytometric urine analysis seemed to
provide such a method. However, such a screening method
would need to perform well in uncomplicated UTIs. Many
cases of uncomplicated UTIs, for example in young, sexually
active women, are likely treated empirically, without resort-
ing to urine culture (17). However, complicated UTIs often
associated with complex underlying pathologies, such as
immunosuppression, are often caused by hospital-related,
antibiotic resistant strains (17). For these infections, a screen-
ing tool for UTI would have to offer reliable detection when
used in a large hospital setting. In this context, it is notable
that some of the studies that evaluated the Sysmex UF-100
excluded hospital acquired infections (12).
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Table 2 Performance of the Sysmex UF-100 at different cut-off thresholds for leukocyte and bacteria counts.
Cut-off Sensitivity, Specificity, False Negative cultures
% % negatives, n avoided/yeara
Leukocytes G15=106/L 87 59 93 12,425
Leukocytes G20=106/L 84 65 115 13,689
Leukocytes G30=109/L 79 73 14 15,374
Bacteria G600=106/L 94 36 41 7582
Bacteria G150=107/L12 88 58 85 12,180
Bacteria G180=107/Lb 83 63 121 13,268
Bacteria G200=107/L 81 66 135 13,900
Bacteria )300=107/L12 75 77 174 16,216
Bacteria )380=107/L18 71 85 179 17,850
Leukocytes G15=106/L OR 98 25 15 5265
Bacteria G500=106/Lc
Leukocytes G30=106/L OR 97 31 23 6529
Bacteria G600=106/L
Leukocytes G111=106/L OR 85 73 107 15,271
Bacteria )300=107/L11
Bacteria )180=107/L OR 90 57 73 12,004
Leukocytes )45=106/L15
Leukocytes G30=106/L OR 88 65 70 13,689
Bacteria G300=107/L OR
Nitrites positive
11, 12, 15, 18sReferences of previous studies from which the cut-off was applied. Sample, (n)s5356 (4650 culture negative and 706
culture positive); aEstimation of the number of urine cultures that be avoided per year based on the assumption that 26,000 cultures are
performed, of which 81% are culture negative (21,060). bManufacturer’s reference cut-off. cBest value for sensitivity. Values in bold indicate
the cut-off that gave best results in terms of sensitivity/specificity.
Although the Sysmex UF-100 detects a large percentage
of UTIs, reported sensitivities are only in the range of
70%–90% (1, 2, 15, 18). However, some investigators
reported higher sensitivities ()95%), but this caused the
specificity to drop to values as low as 15%–49% (11, 12).
Interestingly, the cut offs that were used in these studies var-
ied widely (Table 2) (11, 12, 15, 18). When these cut offs
were applied in the current study, the best sensitivity did not
exceed 90%, with a rather low specificity of 57%. To achieve
the best cut-off, a logical combination of a low leukocyte
count ()15=106/L) and bacterial count (500=106/L) was
used (Table 2). However, this resulted in a large number of
false positives as the specificity decreased to 25%. Extra-
polating these results to 26,000 urine cultures/year that our
laboratory processes, with a 19% positive rate, translates into
99 FN (2%) and 5265 negative urine cultures that would be
avoided. Interestingly, some studies used 300=106 bacteria/
L as the cut-off, with good results for sensitivity (;95%)
and specificity ()60%) (11, 12). However, these studies
included a much smaller number of cultures. For example,
Kim et al. included 330 urine cultures and excluded hospital
acquired infections (12). In addition, one study reported 16
FN out of a total of 427 positive cultures (11). This illustrates
the importance of investigating the usefulness of this method
for screening for all types of UTIs.
It has already been reported that most FN results are
observed primarily in certain patient groups, including those
that are immunosuppressed, renal transplant recipients or
pregnant woman (2). Of course, it is possible that in some
of these cases, microbiologists ‘‘over’’ interpret the urine
culture and consider them significant. However, rigorous
application of criteria, such as the leukocyte count or bac-
terial growth would not support this interpretation. Such
urine specimens most likely would show a negative screen-
ing result using the Sysmex UF-100. Still, one could use
the screening method to exclude unnecessary urine culture
specimens, applying a high cut-off sensitivity of 98% or
99%, and accepting low specificity. For example, applying a
sensitivity of 98% in the authors’ hospital, 5364 cultures
could have been avoided in 2008. Even so, this approach
would have missed 99 positive urine cultures (FN), an unac-
ceptably high number.
In conclusion, the Sysmex UF-100 is a useful method
for screening urine samples for UTI. However, clear cut-off
values are not readily available and are difficult to establish.
For this method to be a useful screening tool for UTI in the
hospital setting, the FN rate would have to be acceptably
low. This, possibly, would require instrument performance
with sensitivity )99% to ensure that clinically important
cases of UTI would not be missed.
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